Zargar Homayoun, Porpiglia Francesco, Porter James, Quarto Giuseppe, Perdona Sisto, Bertolo Riccardo, Autorino Riccardo, Kaouk Jihad H
Center for Laparoscopic and Robotic Surgery, Glickman Urologic and Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44016, USA.
Division of Urology, Department of Oncology, University of Turin "San Luigi" Hospital, Orbassano, Turin, Italy.
World J Urol. 2016 Jul;34(7):925-31. doi: 10.1007/s00345-015-1726-x. Epub 2015 Nov 6.
To validate and compare the values of "MIC" and "trifecta" as predictors of operated kidney functional preservation in a multi-institutional cohort of patients undergoing minimally invasive PN.
We retrospectively reviewed records of consecutive cases of minimally invasive PN performed for cT1 renal masses in 4 centers from 2009 to 2013. Inclusion criteria consisted of availability of a renal scan obtained within 2 weeks prior to surgery and follow-up renal scan 3-6 months after the surgery. The primary endpoint of the study was to compare the degree of ipsilateral renal function preservation assessed by MAG3 renal scan in relation to achievement of MIC and trifecta.
Total of 351 patients met our inclusion criteria. The rates of trifecta achievement for cT1a and cT1b tumors were 78.9 and 60.6 %, respectively. The rate of MIC achievement for cT1a tumors and cT1b tumors was 60.3 and 31.7 %, respectively. On multivariable linear regression model, only the degree of tumor complexity assessed by R.E.N.A.L nephrometry score [coefficient B -1.8 (-2.7, -0.9); p < 0.0001] and the achievement of trifecta [coefficient B 6.1 (2.4,9.8); p = 0.014] or MIC (coefficient B 7.2 (3.8,0.6); p < 0.0001) were significant clinical factors predicting ipsilateral split function preservation.
Achievement of both MIC and "trifecta" is associated with higher proportion of split renal function preservation for cT1 tumors after minimally invasive PN. Thus, these outcome measures can be regarded not only as markers of surgical quality, but also as reliable surrogates for predicting functional outcome in the operated kidney.
在接受微创肾部分切除术(PN)的多机构患者队列中,验证并比较“微创指标(MIC)”和“三联指标”作为手术肾脏功能保留预测指标的价值。
我们回顾性分析了2009年至2013年期间4个中心为cT1期肾肿瘤行微创PN的连续病例记录。纳入标准包括术前2周内获得的肾脏扫描结果以及术后3 - 6个月的随访肾脏扫描结果。本研究的主要终点是比较通过MAG3肾脏扫描评估的同侧肾功能保留程度与微创指标达成情况和三联指标达成情况之间的关系。
共有351例患者符合我们的纳入标准。cT1a和cT1b肿瘤的三联指标达成率分别为78.9%和60.6%。cT1a肿瘤和cT1b肿瘤的微创指标达成率分别为60.3%和31.7%。在多变量线性回归模型中,只有通过R.E.N.A.L肾计量评分评估的肿瘤复杂程度[系数B -1.8(-2.7,-0.9);p < 0.0001]以及三联指标达成情况[系数B 6.1(2.4,9.8);p = 0.014]或微创指标达成情况(系数B 7.2(3.8,0.6);p < 0.0001)是预测同侧肾功能保留的显著临床因素。
对于cT1期肿瘤,微创PN术后实现微创指标和“三联指标”均与更高比例的肾功能保留相关。因此,这些结果指标不仅可被视为手术质量的标志物,还可作为预测手术肾脏功能结局的可靠替代指标。